Anne-Virginie Eggimann is Chief Regulatory Officer at bluebird bio, Inc. (BLUE). They have made 1 open-market trade across 1 company since 2022, most recently 2022-07-12.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BLUE | 42,252 | $210K |
Shares reported on the most recent Form 4, priced at the 2022-07-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BLUE | SELL | 2022-07-12 | 2022-07-14 | $4.95 | $7K | -9.5% | +38.0% | +36.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.